Trial reportAge and ageing2026
A hybrid type 1 trial of a digital behaviour change intervention for frailty prevention in community-dwelling older adults aged 60 years and older.
Trial report in Age and ageing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
aimsThis hybrid type 1 randomised controlled trial evaluated the effectiveness and implementation of a digital behaviour change intervention (DBCI) designed to empower older adults (60+) who are nonfrail and community-dwelling to adopt activity, vaccination, optimising medication, interaction and socialisation, diet and nutrition (AVOID) behaviours to prevent frailty.
methodsSixty adults, from one South Australian local council, were randomised to receive the DBCI (n = 31) or wait (control; n = 29) for 6 months to receive limited DBCI access. Repeated-measures mixed models were used to assess between-group differences in changes in the primary outcome, the frailty index (FI), and the secondary outcome, quality-of-life (QoL; EQ-5D-5L) scores, from baseline to 6 months. Content analysis of survey and focus group data from the intervention group assessed technology acceptance, perceived knowledge and behaviour change. DBCI behaviour change techniques included baseline health and three-month behaviour change reports, education, a library of community resources, goal-setting and action planning and gamification and nudging. Participants in the intervention group received newsletters and were invited to face-to-face expert talks.
resultsThe median age was 75.4 years, and 63.3% of participants were female. In the intervention group, the mean FI score decreased from 0.135 (SD 0.053) to 0.115 (SD 0.071) over 6 months, while in the control group it increased from 0.134 (SD 0.048) to 0.160 (SD 0.087). The intervention group had a mean FI change of -0.044 [95% confidence interval (CI) -0.076 to -0.012] and a mean QoL change of 0.032 (95% CI 0.016 to 0.058) compared with the control group. Qualitative feedback indicated that the DBCI was acceptable, improved knowledge and supported behaviour change across AVOID behaviours.
conclusionA DBCI promoting the adoption of AVOID behaviours among nonfrail, community-dwelling older people is effective in preventing frailty and improving QoL when implemented. Solving technical barriers and incorporating intelligent technologies could enhance impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.